The US FDA has granted fast-track designation for Neuren's NNZ-2591 for the treatment of Pitt Hopkins syndrome. …
FDA grants fast-track designation for Neuren's NNZ-2591 in Pitt Hopkins syndrome
February 19, 2025 Australian Biotech
Latest Video
New Stories
-
AstraZeneca maintains its lead as other teams start to build
February 21, 2025 - - Latest News -
PSA members endorse acquisition of the Australasian College of Pharmacy
February 21, 2025 - - Latest News -
First and only treatment for chronic hypoparathyroidism approved in Australia
February 21, 2025 - - Latest News -
Significant gift new Academy for Health Leadership at University of Melbourne
February 21, 2025 - - Latest News -
A good idea that will need to overcome an institutional mindset
February 19, 2025 - - Latest News -
Pharmaceuticals the latest Trump target for tariffs
February 19, 2025 - - Latest News -
IDT delivers strong first-half performance following strategic pivot
February 19, 2025 - - Latest News